Skip to main content

Walgreens should get a boost from omicron, home testing demand and pediatric vaccines, analysts say

Walgreens raised its full-year guidance during its most recent earnings announcement, with the company expecting an earning boost from COVID-19 in 2022.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.